Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Ultragenyx Pharmaceuticals won approval for its newest gene therapy on Thursday, helping shares partially reverse a catastrophic dive.
The post How This Gene Therapy Name Partially Reversed Its Catastrophic 44% Dive appeared first on Investor’s Business Daily.
